Elisa Agostinetto
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Elisa Agostinetto
Jul 26, 2024, 00:03 |
Blog
Elisa Agostinetto: Must-read by Marleen Kok on the limitations of KEYNOTE-522
Elisa Agostinetto shared on X: "Out in JCO a must-read by Marleen Kok on the…
Jul 19, 2024, 14:02 |
Insight
The results of the IMpassion132 trial
Elisa Agostinetto shared on X a paper by Rebecca Dent et al. titled "IMpassion132 double-blind…
Jul 10, 2024, 12:55 |
Blog
Elisa Agostinetto: 10 key pressure points in the delivery of cancer care that need to be urgently addressed
Elisa Agostinetto shared a policy review by Ajay Aggarwal on X, adding the following: “Out…
Jul 7, 2024, 09:35 |
Insight
Final outcome analysis from TUXEDO-1 trial is out
Elisa Agostinetto shared a paper by Rupert Bartsch et al. on X: “Now out the…
Jun 25, 2024, 07:12 |
Blog
Elisa Agostinetto and Giuseppe Curigliano discuss the results of Destiny-Breast06
Elisa Agostinetto shared on LinkedIn: "At ASCO24 I met Prof Giuseppe Curigliano to discuss the results…
Jun 23, 2024, 02:25 |
Blog
Elisa Agostinetto: Important data for patients who desire pregnancy after a diagnosis of breast cancer
Elisa Agostinetto shared a post by ESMO on X/Twitter: "Are assisted reproductive techniques safe in…
Jun 20, 2024, 11:58 |
Insight
Elisa Agostinetto: A must-read for all oncologists
Elisa Agostinetto recently shared a post on X: "Published in 2023 and yet addressing a…
Jun 18, 2024, 15:34 |
Blog
Elisa Agostinetto: Congrats to Matteo Lambertini for having organized a great YBO event
Elisa Agostinetto shared a post on X: “Congrats to Matteo Lambertini for having organized a great…
Jun 17, 2024, 20:15 |
Insight
Elisa Agostinetto: Commentary on the updated results of DestinyBreast03
Elisa Agostinetto shared on X/Twitter: "Out commentary on the updated results of DestinyBreast03 is out…
Jun 2, 2024, 11:17 |
Societies
Elisa Agostinetto: Do patients with ER-low (1-10%) tumors benefit from adjuvant ET?
Hope Rugo, Professor of Medicine and Director of Breast Oncology and Clinical Trials Education at…
May 20, 2024, 11:18 |
Drugs
Elisa Agostinetto: Our review on emerging treatments for HER2+ breast cancer
Elisa Agostinetto, Clinical Research Fellow at Institute Jules Bordet, shared a post on LinkedIn: “Now…
May 19, 2024, 14:11 |
Societies
20 Posts Not To Miss From ESMOBreast24!
ESMO Breast Cancer 2024 (ESMOBreast24) took place as an onsite and online event in Berlin,…
May 19, 2024, 13:38 |
Insight
Elisa Agostinetto: I discussed the results of our work with Video Journal of Oncology at ESMOBreast24
Elisa Agostinetto, Clinical Research Fellow at Institute Jules Bordet, shared a post on LinkedIn: “At…
May 19, 2024, 02:10 |
Societies
Key messages by Fabrice Andre at ESMOBreast24 session on ctDNA for clinical decision making
Elisa Agostinetto, Medical Oncologist and Research Physician at Jules Bordet, shared on X: . "At…
May 18, 2024, 08:47 |
Blog
Elisa Agostinetto: At ESMO Breast24, Hope Rugo presents results of CAPItello-291
Elisa Agostinetto, Clinical Research Fellow at Institute Jules Bordet, shared a post on X/Twitter: ''At…
May 18, 2024, 04:13 |
Blog
Elisa Agostinetto: Is this a new predictive biomarker for PFS with camizestrant
Elisa Agostinetto, Clinical Research Fellow at Institute Jules Bordet, shared a post on X/Twitter: ''At…
May 18, 2024, 02:04 |
Insight
Elisa Agostinetto: At ESMO Breast24 Christine Desmedt presents an analysis of germline BRCA1/2 mutation
Elisa Agostinetto, Clinical Research Fellow at Institute Jules Bordet, shared on X: “At ESMO Breast24…
May 17, 2024, 15:08 |
Societies
Elisa Agostinetto: our poster exploring histologic subtypes of early breast cancers at ESMOBreast24
Elisa Agostinetto, Clinical Research Fellow at Institute Jules Bordet, shared on X: "At ESMOBreast24, we…
May 8, 2024, 23:17 |
Insight
Giampaolo Bianchini: Join us at the next ESMO Virtual Plenary session!
Elisa Agostinetto, Research Physician at Institute of Jules Bordet in Brussels, shared a post by Giampaolo…
May 7, 2024, 06:28 |
Insight
Elisa Agostinetto: The long and winding road to biomarkers for immunotherapy
Elisa Agostinetto, Clinical Research Fellow at Institute Jules Bordet, shared on LinkedIn: "The long and…
Apr 23, 2024, 10:13 |
Blog
Nikolina Dodlek: We had an opportunity to host the 3rd European Cancer Organisation Young Cancer Professionals group meeting, 1st for this year
Nikolina Dodlek, Head Nurse Department for Oncology at University Hospital Centre Osijek, shared on LinkedIn:…
Apr 20, 2024, 14:18 |
Blog
Elisa Agostinetto: The proportion of patients with an actionable alteration (AA) in serial cfDNA decreases with time
Elisa Agostinetto, Clinical Research Fellow at Jules Bordet Institute in Brussels, shared a post on…
Apr 15, 2024, 17:01 |
Drugs
Elisa Agostinetto: It’s likely that adjuvant Pembrolizumab has a lower impact compared to neoadjuvant Pembrolizumab
Elisa Agostinetto, Research Physician at the Institute of Jules Bordet in Brussels, posted on X/Twitter:…
Apr 3, 2024, 15:19 |
Insight
Elisa Agostinetto: A pooled analysis exploring tumor intrinsic subtypes in 3 trials on HER2+ EBC
Elisa Agostinetto, Research Physician at Institute of Jules Bordet in Brussels, posted on X/Twitter: "Out…
Mar 29, 2024, 06:30 |
Insight
Elisa Agostinetto: Important meta-analysis in NPJ Journals Breast shedding light on one of the biggest unmet needs in breast oncology
Elisa Agostinetto, Medical Oncologist and Research Fellow at Jules Bordet Institute in Brussels, posted on…
Mar 22, 2024, 22:58 |
Blog
Elisa Agostinetto: Our subanalysis of the CLEOPATRA study led by Veronique Debien
Elisa Agostinetto, Clinical Research Fellow at Jules Bordet Institute in Brussels, shared a post on…
Mar 15, 2024, 15:38 |
Blog
Elisa Agostinetto: Our last meta-analysis led by Guilherme Nader Marta shows that ctDNA detection in early breast cancer is associated with higher risk of recurrence
Elisa Agostinetto, Clinical Research Fellow at Jules Bordet Institute in Brussels, shared a post on…
Mar 12, 2024, 20:36 |
Societies
Elisa Agostinetto: Happy to receive a ESMO Merit Travel Grant for the upcoming ESMO Breast24
Elisa Agostinetto, Research Fellow at Jules Bordet Institute in Brussels, shared a post on X/Twitter: "Happy to receive…
Feb 16, 2024, 18:13 |
Blog
Elisa Agostinetto: Nice editorial out in Journal of Clinical Oncology on the design, analysis, and reporting of research that involves real-world data
Elisa Agostinetto, Research Fellow at Jules Bordet Institute, shared a post on X/Twitter: "Nice editorial out…
Jan 28, 2024, 18:29 |
Blog
Elisa Agostinetto: Estradiol levels remain the biomarker of choice
Elisa Agostinetto, Clinical Research Fellow at the Institute Jules Bordet, recently shared on X/Twitter: "Out…
Dec 20, 2023, 12:00 |
Insight
Elisa Agostinetto: Blinded independent central review (BICR) in clinical trials is it really needed
Elisa Agostinetto, Medical Research Fellow at Jules Bordet Institute in Brussels, recently posted X/Twitter: ''Blinded…
Dec 17, 2023, 17:26 |
Blog
25 Posts Not To Miss From SABCS 2023
The San Antonio Breast Cancer Symposium 2023 (SABCS 2023) took place in San Antonio, Texas…
Nov 16, 2023, 17:35 |
Blog
Daniel Portik: Full house at the Young Cancer Professionals meeting of the European Cancer Summit hosted by European Cancer Organisation
Daniel Portik, RTQA Fellow at EORTC, shared a post on LinkedIn: “Full house at the…
Oct 4, 2023, 21:11 |
Blog
Elisa Agostinetto: Proud to be part of Institut Jules Bordet team and to work everyday with extraordinary colleagues and mentors to help fight against breast cancer.
Elisa Agostinetto, Clinical Research Fellow at Institute Jules Bordet, shared the following post on Twitter: "This…
All:
34
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube